Phase
Condition
Narcolepsy
Sleep Disorders
Insomnia
Treatment
Remimazolam
normal Saline
Esketamine
Clinical Study ID
Ages 18-45 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 18-45 years old;
American society of Aneshesiologists(ASA)physical status classification system isgrade I-III;
Elective surgery is proposed
BMI of 19-30 kg/m2;
Patients who agreed to enroll in this study voluntarily
Exclusion
Exclusion Criteria:
Those who are known to be allergic to the drug ingredients in this study and theirallergic constitution;
Allergic history of general anesthesia drugs, opioid drugs, non-steroidal drugs;
History of neurological diseases; History of chronic pain; Drug and alcoholaddiction; A long history of opioid use; Opiates were given 48 hours before surgery
Coronary heart disease, bronchial asthma, severe hypertension, severe blood systemdysfunction, liver and kidney function, electrolyte abnormalities;
Respiratory insufficiency, respiratory failure;
BMI<18 kg/m2 or BMI>30kg/m2;
Poor compliance, unable to complete the experiment according to the study plan;Participants who have participated in clinical trials of other drugs within the last 4 weeks;
Preoperative Pittsburgh Sleep Quality Index (PSQI) higher than 7
Any circumstances deemed unsuitable for inclusion by the researcher for any reason.
Study Design
Study Description
Connect with a study center
Tianjin Medical University General Hospital
Tianjin, 300052
ChinaSite Not Available
Tianjin Medical University General Hospital
Tianjin 1792947, 300052
ChinaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.